Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
D001127:Arginine Vasopressin / Q000627:therapeutic use*; D002648:Child; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology / Q000627:therapeutic use*; D005169:Factor VIII / Q000378:metabolism; D005260:Female; D006801:Humans; D007123:Immunoelectrophoresis, Two-Dimensional; D014842:von Willebrand Diseases / Q000097:blood / Q000188:drug therapy*
D001127:Arginine Vasopressin; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin